Nominations for the MCIA Olivia Newton-John Service To Industry Award are open. “The Medicinal Cannabis Industry Australia is pleased and excited to launch the Olivia Newton-John Service to Industry award”, said Mr Peter Crock, MCIA Chair, “and were particularly honoured to have Olivia’s husband Mr John Easterling formerly open the call for nominations for the inaugural 2023 Service to Industry Award”.Continue reading “Nominations for the MCIA Olivia Newton-John Service To Industry Award are open”
MCIA and relevant industry news
MCIA are deeply saddened to hear of the passing of Dame Olivia Newton-John
Olivia was an inspirational and vocal advocate for medicinal cannabis. She knew the important role medicinal cannabis could play in the journey of a cancer patient and was passionate about increased patient access.
When MCIA launched, she was excited to see the industry come together to discuss these important issues to ensure all patients had access to medicinal cannabis.Continue reading “MCIA are deeply saddened to hear of the passing of Dame Olivia Newton-John”
How will the Australian medicinal cannabis industry evolve?
NEW REPORT RELEASED
Developed by MTPConnect in partnership with Deloitte Access Economics, MCIA was pleased to initiate consultation with MTPConnect to develop this evidence based report for the industry and we thank MTPConnect for their support and work in developing this resource.Continue reading “How will the Australian medicinal cannabis industry evolve?”
COVID19 – Medicinal Cannabis an Essential Service
Medicinal Cannabis Industry Australia (MCIA) has undertaken consultation with the Federal and State Governments and has received confirmation that medicinal cannabis qualifies as an essential service under the public health orders issued by the States and Territories. The public health orders note that sectors/activities where working remotely is not an option, and getting medical care or supplies, are essential services exempt from the social distancing restrictions. Thus, companies will be working to keep the medicinal supply operational and will implement appropriate protocols and practices to ensure the safety of employees and minimise disruptions to supply of products to patients.